N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine

C102H101BrF4N22O10S — CID 157150605

IUPACN-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine
SMILESCCC#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.COc1cc(OC)c(F)c(N(CCCNCC(C)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F.COc1cc(OC)cc(N(CC#Cc2cccnc2Br)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1
InChIInChI=1S/C28H23BrN6O2.C26H28F4N6O2.C25H25N5O2.C23H25N5O4S/c1-34-18-20(16-32-34)27-17-31-25-9-8-21(14-26(25)33-27)35(11-5-7-19-6-4-10-30-28(19)29)22-12-23(36-2)15-24(13-22)37-3;1-26(29,30)15-31-8-5-9-36(25-23(27)21(37-3)11-22(38-4)24(25)28)17-6-7-18-19(10-17)34-20(13-32-18)16-12-33-35(2)14-16;1-5-6-7-10-30(20-11-21(31-3)14-22(12-20)32-4)19-8-9-23-24(13-19)28-25(16-26-23)18-15-27-29(2)17-18;1-27-15-16(13-25-27)23-14-24-21-6-5-17(11-22(21)26-23)28(7-8-33(4,29)30)18-9-19(31-2)12-20(10-18)32-3/h4,6,8-10,12-18H,11H2,1-3H3;6-7,10-14,31H,5,8-9,15H2,1-4H3;8-9,11-17H,5,10H2,1-4H3;5-6,9-15H,7-8H2,1-4H3
InChIKeyALFFBQMACTURBG-UHFFFAOYSA-N
MW1983.04 g/mol
LogP18.32
Rot. Bonds31

About N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine

N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine (PubChem CID 157150605) has the molecular formula C102H101BrF4N22O10S and a molecular weight of 1983.04 g/mol. Its IUPAC name is N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine.

Molecular Properties

Compound NameN-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine
PubChem CID157150605
Molecular FormulaC102H101BrF4N22O10S
Molecular Weight1983.04 g/mol
Exact Mass1980.69
IUPAC NameN-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine
SMILESCCC#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.COc1cc(OC)c(F)c(N(CCCNCC(C)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F.COc1cc(OC)cc(N(CC#Cc2cccnc2Br)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1
InChIInChI=1S/C28H23BrN6O2.C26H28F4N6O2.C25H25N5O2.C23H25N5O4S/c1-34-18-20(16-32-34)27-17-31-25-9-8-21(14-26(25)33-27)35(11-5-7-19-6-4-10-30-28(19)29)22-12-23(36-2)15-24(13-22)37-3;1-26(29,30)15-31-8-5-9-36(25-23(27)21(37-3)11-22(38-4)24(25)28)17-6-7-18-19(10-17)34-20(13-32-18)16-12-33-35(2)14-16;1-5-6-7-10-30(20-11-21(31-3)14-22(12-20)32-4)19-8-9-23-24(13-19)28-25(16-26-23)18-15-27-29(2)17-18;1-27-15-16(13-25-27)23-14-24-21-6-5-17(11-22(21)26-23)28(7-8-33(4,29)30)18-9-19(31-2)12-20(10-18)32-3/h4,6,8-10,12-18H,11H2,1-3H3;6-7,10-14,31H,5,8-9,15H2,1-4H3;8-9,11-17H,5,10H2,1-4H3;5-6,9-15H,7-8H2,1-4H3
InChIKeyALFFBQMACTURBG-UHFFFAOYSA-N
XLogP18.32
TPSA320.26 Ų
H-Bond Donors1
H-Bond Acceptors32
Rotatable Bonds31
Heavy Atoms140
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001983.04
LogP ≤ 518.32
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine?
The IUPAC name of N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine (CID 157150605) is N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine.
What is the SMILES notation for N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine?
The canonical SMILES for N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine is CCC#CCN(c1cc(OC)cc(OC)c1)c1ccc2ncc(-c3cnn(C)c3)nc2c1.COc1cc(OC)c(F)c(N(CCCNCC(C)(F)F)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1F.COc1cc(OC)cc(N(CC#Cc2cccnc2Br)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.COc1cc(OC)cc(N(CCS(C)(=O)=O)c2ccc3ncc(-c4cnn(C)c4)nc3c2)c1.
What is the InChIKey of N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine?
The InChIKey is ALFFBQMACTURBG-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H23BrN6O2.C26H28F4N6O2.C25H25N5O2.C23H25N5O4S/c1-34-18-20(16-32-34)27-17-31-25-9-8-21(14-26(25)33-27)35(11-5-7-19-6-4-10-30-28(19)29)22-12-23(36-2)15-24(13-22)37-3;1-26(29,30)15-31-8-5-9-36(25-23(27)21(37-3)11-22(38-4)24(25)28)17-6-7-18-19(10-17)34-20(13-32-18)16-12-33-35(2)14-16;1-5-6-7-10-30(20-11-21(31-3)14-22(12-20)32-4)19-8-9-23-24(13-19)28-25(16-26-23)18-15-27-29(2)17-18;1-27-15-16(13-25-27)23-14-24-21-6-5-17(11-22(21)26-23)28(7-8-33(4,29)30)18-9-19(31-2)12-20(10-18)32-3/h4,6,8-10,12-18H,11H2,1-3H3;6-7,10-14,31H,5,8-9,15H2,1-4H3;8-9,11-17H,5,10H2,1-4H3;5-6,9-15H,7-8H2,1-4H3.
What are the key properties of N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine?
N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine has a molecular weight of 1983.04 g/mol, XLogP of 18.32, 31 rotatable bonds, 1 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(2-bromo-3-pyridinyl)prop-2-ynyl]-N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)quinoxalin-6-amine;N'-(2,6-difluoro-3,5-dimethoxyphenyl)-N-(2,2-difluoropropyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]propane-1,3-diamine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-(2-methylsulfonylethyl)quinoxalin-6-amine;N-(3,5-dimethoxyphenyl)-3-(1-methylpyrazol-4-yl)-N-pent-2-ynylquinoxalin-6-amine is sourced from PubChem (CID 157150605), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).